Quadrant Capital Group LLC United Therapeutics Corp Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 744 shares of UTHR stock, worth $275,897. This represents 0.02% of its overall portfolio holdings.

Number of Shares

744

Previous 703 5.83%

Holding current value

$275,897

Previous $223,000 19.28%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$311.04 - $363.55 $12,752 - $14,905	41 Added 5.83%	744 $266,000
Q2 2024 Aug 12, 2024	BUY	$228.26 - $319.04 $51,358 - $71,784	225 Added 47.07%	703 $223,000
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $21,708 - $25,699	-103 Reduced 17.73%	478 $109,000
Q4 2023 Feb 08, 2024	BUY	$214.88 - $256.94 $29,653 - $35,457	138 Added 31.15%	581 $127,000
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $32,196 - $37,732	-152 Reduced 25.55%	443 $100,000
Q2 2023 Aug 09, 2023	BUY	$205.19 - $232.99 $35,703 - $40,540	174 Added 41.33%	595 $131,000
Q1 2023 May 11, 2023	SELL	$212.99 - $276.17 $19,169 - $24,855	-90 Reduced 17.61%	421 $94,000
Q4 2022 Feb 10, 2023	BUY	$205.95 - $280.43 $35,217 - $47,953	171 Added 50.29%	511 $142,000
Q3 2022 Nov 10, 2022	BUY	$203.3 - $244.17 $23,379 - $28,079	115 Added 51.11%	340 $71,000
Q2 2022 Aug 09, 2022	BUY	$174.81 - $241.14 $13,285 - $18,326	76 Added 51.01%	225 $53,000
Q1 2022 May 06, 2022	SELL	$166.16 - $213.96 $2,326 - $2,995	-14 Reduced 8.59%	149 $27,000
Q4 2021 Feb 01, 2022	SELL	$184.32 - $216.08 $11,980 - $14,045	-65 Reduced 28.51%	163 $35,000
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $9,532 - $11,388	53 Added 30.29%	228 $42,000
Q2 2021 Aug 09, 2021	SELL	$170.47 - $211.93 $681 - $847	-4 Reduced 2.23%	175 $31,000
Q1 2021 May 12, 2021	BUY	$153.94 - $174.85 $2,001 - $2,273	13 Added 7.83%	179 $30,000
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $3,361 - $5,009	33 Added 24.81%	166 $25,000
Q3 2020 Nov 13, 2020	BUY	$99.9 - $121.13 $4,395 - $5,329	44 Added 49.44%	133 $13,000
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $54,623 - $74,107	-589 Reduced 86.87%	89 $11,000
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $238 - $346	3 Added 0.44%	678 $64,000
Q4 2019 Feb 03, 2020	BUY	$78.31 - $95.34 $1,096 - $1,334	14 Added 2.12%	675 $55,000
Q3 2019 Oct 24, 2019	BUY	$74.85 - $85.99 $18,787 - $21,583	251 Added 61.22%	661 $50,000
Q2 2019 Jul 24, 2019	SELL	$76.06 - $120.81 $6,008 - $9,543	-79 Reduced 16.16%	410 $29,000
Q1 2019 Apr 29, 2019	BUY	$107.15 - $126.84 $44,360 - $52,511	414 Added 552.0%	489 $55,000
Q2 2018 Aug 09, 2018	BUY	$101.14 - $118.31 $1,820 - $2,129	18 Added 31.58%	75 $7,000
Q1 2018 May 10, 2018	SELL	$107.21 - $151.94 $3,645 - $5,165	-34 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$118.58 - $151.28 $5,573 - $7,110	-47 Reduced 58.02%	34 $4,000
Q3 2017 Oct 13, 2017	BUY	$114.6 - $136.81 $1,948 - $2,325	17 Added 26.56%	81 $7,000
Q2 2017 Aug 15, 2017	BUY	N/A	64	64 $6,000

Others Institutions Holding UTHR

# of Institutions

679

Shares Held

42.1M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC United Therapeutics Corp Transaction History